Case-ControlControl. None

Size: px
Start display at page:

Download "Case-ControlControl. None"

Transcription

1 Study Designs & Methodologies (w/ /M Measures of Association) What is the most useful and appropriate study design? Larry W. Segars, PharmD, DrPH, FCCP, FACE, BCPS, RPh Associate Dean College of Biosciences Associate Professor of Pharmacology College of Medicine None Conflicts of Interest What is the most useful and appropriate study design? Learning Objectives Study Designs Describe, differentiate, and be able to recognize the structure, methods and designs of the common types of observational & interventional studies. Delineate, differentiate, and be able to recognize the common types of perspectives utilized by observational and interventional studies. Describe the purpose of Randomization and how one can confirm its success, and also describe and differentiate between the 3 common forms of randomization. Delineate and differentiate the common methods of handling lost to follow up/drop outs associated with studies. Delineate, calculate, and interpret common terms associated with comparing groups based on measures of association for disease (or outcome) occurrence. Increas ing Evidence Interventional Pre-Clinical * Phase 1 Phase 2 Phase 3 Phase 4 Observational Cases * (Reports/Series) Ecological * Cross-Sectional Case-ControlControl Cohort Increas ing Evidence 1

2 2 KEY QUESTIONS to Selecting the Correct Study Design 1. Is researcher FORCING GROUP ALLOCATION? a. Yes Interventional (sample size/duration/focus) b. No Observational ( outcome / exposure ) ) Case Control Control Study Disease/Outcome NO Exposed Non-Exposed Population Exposed Disease/Outcome YES Non-Exposed CASE CONTROL CONTROL design useful when studying a rare disease Commonly generates the Odds Ratio (OR) as measure of association 2 KEY QUESTIONS to Selecting the Correct Study Design 1. Is researcher FORCING GROUP ALLOCATION? a. Yes Interventional (sample size/duration/focus) b. No Observational ( outcome / exposure ) ) 2. For Observational studies, how were groups ORGANIZED? Considering OUTCOME vs. EXPOSURE, Look for what is KNOWN vs. being SOUGHT a. By Outcome Status Case Control/ Control/Nested Case ControlControl b. By Exposure Status Cohort c. By Common Factor Cross Sectional or Cohort Population Cohort Study Exposure -NO Exposure - YES Diseased/Outcome Non-Diseased/ No Outcome Diseased/Outcome Non-Diseased/ No Outcome COHORT design useful when studying a rare exposure Commonly generates the Risk Ratio (RR) as measure of association Studies can be : PROSPECTIVE outcome is NOT yet known at start of study RETROSPECTIVE outcome IS already known at start of study AMBIDIRECTIONAL (both perspectives in same study) First looking retrospectively, then looking prospectively for additional outcomes Observational Studies: Cohort Study (a.k.a. Longitudinal & Follow up Study) DEFINITION vs. STUDY METHODOLOGY 1. StudyMethodology: Group organization based on EXPOSURE status (presence/absence) 2. Definition: A group with something in common Birth / Inception / Exposure / etc 2

3 NHANES or Observational Studies Cont d: Nested Case ControlControl A Case ControlControl study derived out of a completed Cohort study The diseased study subjects determined from Cohort study becoming Cases of a different, subsequent study»includes new subjects without disease, called Controls, who may or may not have necessarily come from the original Cohort study Interventional Studies: Pre Clinical An investigation conducted in non humans or in vitro Phase 1 (new treatment (medication/device) Small N (20 80), healthy volunteers, first time use in humans to assess short term safety, toxicity and pharmacokinetics (A D M E) Short duration (e.g., a couple of days to a few weeks) Phase 2 (new treatment (medication/device), indication or population) Larger N ( ), commonly utilize patients with condition of interest, used to expand on purpose of Phase 1 study (short term safety) but also to begin assessing efficacy in a diseased population Short to Medium duration (e.g., a few weeks to a few months) Likely to have narrow inclusion criteria Observational Studies Cont d: Cross Sectional Study (a.k.a.; Prevalence study) Purpose: Examines relationships between disease AND exposure (simultaneously) among individuals in a defined study population at a point in time A snap shot in time (across the entire study population) Patient selection: inclusion in large study population Think of a cross sectional study when the information gathered represents what is going on with disease AND exposures (at the same time) a cross an entire (large) study population Interventional Studies Cont d: Phase 3 (new treatment (medication/device), indication or population) Larger N (500 3,000), used in patients with the condition of interest to continue determination of short to intermediate safety, with primary purpose to assess efficacy (broader inclusion criteria; more clinically relevant (yet still possible to limit generalizability to full population) Longer duration (e.g., a few to numerous months; may up to 1 3 years)» Superiority & Non Inferiority perspectives utilized Phase 4 (post marketing/post FDA approval) Longer term effects (risks & benefits) in a large population of diseased patients (expanded use population (age, ethnic)) Registries, Survey s (or via FDA s MedWatch program) 3

4 Example Board Questions Researchers randomly select 12,980 patients in the San Antonio Military Multi Service Market who were being treated with a statin medication and 45,997 patients in this same Market who were not treated with a statin. The researchers wish to investigate a possible association between treatment with a stain and the incidenceof various musculoskeletal and neoplastic diseases between statin users and non users. Which of the following study types would be most appropriate? A. Cohort study B. Phase 3 clinical trial C. Case Control study D. Case Series E. Phase 4 clinical trial Researchers randomly select 100 patients with newly diagnosed oropharyngeal cancer and 200 patients without this cancer, and wish to investigate a possible association between HPV infection and oropharyngeal cancer. Which of the following study types would be most appropriate? A. Cohort study B. Case Control study C. Phase 2 study D. Case Series E. Phase 3 study Researchers randomly select 12,980 patients in the San Antonio Military Multi Service Market who were being treated with a statin medication and 45,997 patients in this same Market who were not treated with a statin. The researchers wish to investigate a possible association between treatment with a stain and the incidenceof various musculoskeletal and neoplastic diseases between statin users and non users. Which of the following study types would be most appropriate? A. Cohort study B. Phase 3 clinical trial C. Case Control study D. Case Series E. Phase 4 clinical trial Am J Med Sci 2013;345: Researchers randomly select 100 patients with newly diagnosed oropharyngeal cancer and 200 patients without this cancer, and wish to investigate a possible association between HPV infection and oropharyngeal cancer. Which of the following study types would be most appropriate? A. Cohort study B. Case Control study C. Phase 2 study D. Case Series E. Phase 3 study NEJM 2007;356: Researchers desire to evaluate the safety and efficacy of treating gout with allopurinol versus febuxostat. Researchers plan to randomize patients with confirmed gout to treatment with either febuxostat 10 mg/d or allopurinol 100 mg/d initially for 12 days, and then permit dose titration, as clinically deemed appropriate, up to 40 mg/d and 200 mg/d, respectively, over a total of 8 weeks. Which of the following study designs would be most appropriate? A. Case Control B. Phase 1 D. Cross sectional E. Phase 3 4

5 Researchers desire to evaluate the safety and efficacy of treating gout with allopurinol versus febuxostat. Researchers plan to randomize patients with confirmed gout to treatment with either febuxostat 10 mg/d or allopurinol 100 mg/d initially for 12 days, and then permit dose titration, as clinically deemed appropriate, up to 40 mg/d and 200 mg/d, respectively, over a total of 8 weeks. Which of the following study designs would be most appropriate? A. Case Control B. Phase 1 D. Cross sectional E. Phase 3 J Clin Rheumatol 2011;17:S13 S18. S18. Researchers desired to compare the efficacy and tolerability of a fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus a fixed combination of timolol maleate 0.5%/dorzolamide 2% over 8 weeks in patients with elevated IOP. Researchers utilized an open labeled, randomized format in 5 centers across 2 countries. Which of the following study designs would be most appropriate? A. Phase 2 B. Case Control D. Phase 4 E. Cross sectional Researchers utilized the National Ambulatory Medical Care Survey to evaluate the use of HMG CoA reductase inhibitors in U.S. diabetics. The researchers used survey data from to evaluate differences in patient characteristics between those U.S. diabetics treated with a statin medication versus those not treated with these medications, while controlling for potential confounders. Which of the following study designs most appropriately represents the utilized study design? A. Case Control B. Phase 3 D. Cross sectional E. Phase 2 Researchers desired to compare the efficacy and tolerability of a fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus a fixed combination of timolol maleate 0.5%/dorzolamide 2% over 8 weeks in patients with elevated IOP. Researchers utilized an open labeled, randomized format in 5 centers across 2 countries. Which of the following study designs would be most appropriate? A. Phase 2 B. Case Control D. Phase 4 E. Cross sectional J Glaucoma 2008;17: Researchers utilized the National Ambulatory Medical Care Survey to evaluate the use of HMG CoA reductase inhibitors in U.S. diabetics. The researchers used survey data from to evaluate differences in patient characteristics between those U.S. diabetics treated with a statin medication versus those not treated with these medications, while controlling for potential confounders. Which of the following study designs most appropriately represents the utilized study design? A. Case Control B. Phase 3 D. Cross sectional E. Phase 2 Clin Therapeutics 2008;30: Group Allocation Procedures: Non Random e.g., Alternating subjects based on fixed criteria (odd/even days; every other patient; etc, etc ) Random (most common utilized) Subjects have equal probability of being assigned to each of the predefined intervention groups Random number table or Computer program random number generator Randomization Purpose: to make all groups as equal as possible; based on known (and potentially unknown) confounders Attempts to reduces systematic difference (bias) between groups which could impact results/outcomes Table 1 customarily used to show group baseline characteristics Equal ness of groups not guaranteed! 5

6 Common Types of Randomization Processes: Blocked (Permuted Blocked) Ensures balance within each intervention group Stratified Subjects separated and balanced by known confounding variables Examples: Gender, Age group, Disease severity, etc Can also pre select levels to be balanced within each prognostic factor (confounder)»very useful when confounders are known and sample size is not very large Managing Drop Outs/Lost Outs/Lost to Follow Up: Include Them Intent to Treat (most conservative) Use last known assessment for remaining (missed) study evaluations, OR Exclude Them Per Protocol (a.k.a., Efficacy Analysis) Must meet pre established level of compliance/participation to be included Formats of Interventional Studies: Parallel Subjects exclusively managed in originally randomized group No switching of groups Study Strengths/Weaknesses (Broad) Ability to prove Causation Validity (Accuracy/Precision/Consistency) Measurements / Assessments / Classifications Applicability (External Validity) Inclusion / Exclusion criteria Others (Ethics / Cost / Time requirement) Formats of Interventional Studies: Cross Over (a.k.a., Self Control) Subjects switched to different interventions at one or more points after initial randomization Between & Within Group comparisons possible Differentiate Wash out vs Lead in ; Run in Measures of Association Interpreting RATIO s Risk (RR), Odds (OR), Hazard (HR): =1.0 = no difference (no increase/no decrease) in risk/odds/ratio >1.0 = Increased Ratio (RR/OR/HR) to = use decimal value (converted to %) for interpretation If RR = 1.53, then a 53% increased (greater) risk in comparator group»increased because ratio value is ABOVE = use statement of times control for interpretation +2.0 to If OR = 6.18, then comparator group is 6.18 times greater odds»greater because ratio value is ABOVE 1.0 <1.0 = Decreased Ratio (RR/OR/HR) to 0.99 = subtract decimal value from 1 (answer converted to %) for interpretation If HR = 0.73, then a 27% lower probability of the hazard outcome»lower because ratio value is BELOW 1.0 6

7 Measures of Association When Interpreting Ratio s [RR/OR/HR], look for : RR = Group Comparison Orientation a. Ramipril vs. Placebo / Placebo vs. Ramipril 2. Direction of words a. Increased / Decreased 3. Magnitude a. 1.8 is 80% or 1.8 times / 0.8 is 20% or 0.8 times When looking at the CI for Ratio s (RR/OR/HR), if both values are on the SAME SIDE of 1.0, it is always statistically significant! Example Board Questions Measures of Association Absolute Risk Reduction (ARR) [a.k.a. Attributable Risk (AR)] Simple Absolute Difference (subtraction) in Risks AR defines the risk difference in the outcome among Exposed that can be attributed attributed to the actual exposure Ramipril = 14% & Placebo = 17.8% ARR = 3.8% A retrospective cohort study was conducted in 100 subjects living in a small village in Ethiopia. The study evaluated the frequency of developing intestinal infectious disease associated with exposure to contaminated pond water. The study determined the risk ratio (RR) to be Which of the following is the most appropriate interpretation of this finding? Additional Representations Number Needed to Treat (NNT) 1 Absolute Risk Reduction (1/ARR) From ramipril example: = 26.32; [27 Patients] Interpretation: Number of (whole) patients needed to be treated to experience the studied event outcome Outcome event can be a Beneficial or Harmful event A retrospective cohort study was conducted in 100 subjects living in a small village in Ethiopia. The study evaluated the frequency of developing intestinal infectious disease associated with exposure to contaminated pond water. The study determined the risk ratio (RR) to be Which of the following is the most appropriate interpretation of this finding? A. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 2.54 times more likely to develop intestinal disease. B. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 54% more likely to develop intestinal disease. C. Compared to subjects exposed to the contaminated pond water, subjects not exposed to the pond water were 62.5% less likely to develop intestinal disease. D. Compared to subjects exposed to the contaminated pond water, subjects not exposed to the pond water were 2.54 times more likely to develop intestinal disease. E. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 200% more likely to develop intestinal disease. 7

8 A retrospective cohort study was conducted in 100 subjects living in a small village in Ethiopia. The study evaluated the frequency of developing intestinal infectious disease associated with exposure to contaminated pond water. The study determined the risk ratio (RR) to be Which of the following is the most appropriate interpretation of this finding? A. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 2.54 times more likely to develop intestinal disease. B. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 54% more likely to develop intestinal disease. C. Compared to subjects exposed to the contaminated pond water, subjects not exposed to the pond water were 62.5% less likely to develop intestinal disease. D. Compared to subjects exposed to the contaminated pond water, subjects not exposed to the pond water were 2.54 times more likely to develop intestinal disease. E. Compared to subjects not exposed to the pond water, subjects exposed to the contaminated pond water were 200% more likely to develop intestinal disease. A clinical trial was conducted to determine the impact of dual treatment for hypertensive emergencies compared to single agent therapy. Based on the study findings, the risk of death from hypertensive emergency in the dualtreatment group was 13% compared to 27% in the single agent treatment group. Based on these findings, which of the following values most closely represents the number needed to treat (NNT) and its proper interpretation? A. A total of 7 patients would have to be treated with dual agent agent therapy to reduce one death following a hypertensive emergency B. A total of 14 patients would have to be treated with a single agent to reduce one death following a hypertensive emergency C. A total of 13 patients out of 100 (13%) would have to be treated with dual agent therapy to reduce one death from a hypertensive emergency D. If a total of 14 patients were treated with dual agent therapy for a hypertensive emergency, it would lead the a single death E. A total of 7 patients out of 100 (7%) would die from hypertensive emergency if treated with dual agent therapy A clinical trial was conducted to determine the impact of dual treatment for hypertensive emergencies compared to single agent therapy. Based on the study findings, the risk of death from hypertensive emergency in the dualtreatment group was 13% compared to 27% in the single agent treatment group. Based on these findings, which of the following values most closely represents the number needed to treat (NNT) and its proper interpretation? SUMMARY Appropriate study design selection based on study question, purpose, and group allocation format Every study has its unique strengths & weaknesses Risk difference (ARR) used to easily determine NNT RR and OR are simply ratio s of 2 risks ik or odds and interpreted exactly the same (as is HR) Calculation & Interpretation of (OR/RR) is useful A clinical trial was conducted to determine the impact of dual treatment for hypertensive emergencies compared to single agent therapy. Based on the study findings, the risk of death from hypertensive emergency in the dualtreatment group was 13% compared to 27% in the single agent treatment group. Based on these findings, which of the following values most closely represents the number needed to treat (NNT) and its proper interpretation? A. A total of 7 patients would have to be treated with dual agent agent therapy to reduce one death following a hypertensive emergency B. A total of 14 patients would have to be treated with a single agent to reduce one death following a hypertensive emergency C. A total of 13 patients out of 100 (13%) would have to be treated with dual agent therapy to reduce one death from a hypertensive emergency D. If a total of 14 patients were treated with dual agent therapy for a hypertensive emergency, it would lead the a single death E. A total of 7 patients out of 100 (7%) would die from hypertensive emergency if treated with dual agent therapy QUESTIONS? 8

GLOSSARY OF GENERAL TERMS

GLOSSARY OF GENERAL TERMS GLOSSARY OF GENERAL TERMS Absolute risk reduction Absolute risk reduction (ARR) is the difference between the event rate in the control group (CER) and the event rate in the treated group (EER). ARR =

More information

Epidemiologic study designs

Epidemiologic study designs Epidemiologic study designs and critical appraisal of scientific papers Rolf H.H. Groenwold, MD, PhD Bio sketch MD, PhD in epidemiology Associate professor of Epidemiology at UMC Utrecht Research focus

More information

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies Observational Study Designs Denise Boudreau, PhD Center for Health Studies Group Health Cooperative Today Review cohort studies Case-control studies Design Identifying cases and controls Measuring exposure

More information

Epidemiologic Methods and Counting Infections: The Basics of Surveillance

Epidemiologic Methods and Counting Infections: The Basics of Surveillance Epidemiologic Methods and Counting Infections: The Basics of Surveillance Ebbing Lautenbach, MD, MPH, MSCE University of Pennsylvania School of Medicine Nothing to disclose PENN Outline Definitions / Historical

More information

Trial Designs. Professor Peter Cameron

Trial Designs. Professor Peter Cameron Trial Designs Professor Peter Cameron OVERVIEW Review of Observational methods Principles of experimental design applied to observational studies Population Selection Looking for bias Inference Analysis

More information

Protocol Development: The Guiding Light of Any Clinical Study

Protocol Development: The Guiding Light of Any Clinical Study Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the

More information

observational studies Descriptive studies

observational studies Descriptive studies form one stage within this broader sequence, which begins with laboratory studies using animal models, thence to human testing: Phase I: The new drug or treatment is tested in a small group of people for

More information

JAMA. 2011;305(24): Nora A. Kalagi, MSc

JAMA. 2011;305(24): Nora A. Kalagi, MSc JAMA. 2011;305(24):2556-2564 By Nora A. Kalagi, MSc Cardiovascular disease (CVD) is the number one cause of mortality and morbidity world wide Reducing high blood cholesterol which is a risk factor for

More information

Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course

Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course Study Designs: Fundamentals and Interpretation Kevin M. Sowinski, Pharm.D., FCCP Purdue University, College

More information

Statistics for Clinical Trials: Basics of Phase III Trial Design

Statistics for Clinical Trials: Basics of Phase III Trial Design Statistics for Clinical Trials: Basics of Phase III Trial Design Gary M. Clark, Ph.D. Vice President Biostatistics & Data Management Array BioPharma Inc. Boulder, Colorado USA NCIC Clinical Trials Group

More information

Beyond the intention-to treat effect: Per-protocol effects in randomized trials

Beyond the intention-to treat effect: Per-protocol effects in randomized trials Beyond the intention-to treat effect: Per-protocol effects in randomized trials Miguel Hernán DEPARTMENTS OF EPIDEMIOLOGY AND BIOSTATISTICS Intention-to-treat analysis (estimator) estimates intention-to-treat

More information

Learning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

Learning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Last-Chance Ambulatory Care Webinar Thursday, September 5, 2013 Learning Objectives For

More information

Delfini Evidence Tool Kit

Delfini Evidence Tool Kit General 1. Who is sponsoring and funding the study? What are the affiliations of the authors? Study Design Assessment Internal Validity Assessment Considerations: This can be helpful information and is

More information

Evidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013

Evidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013 Evidence-Based Medicine Journal Club A Primer in Statistics, Study Design, and Epidemiology August, 2013 Rationale for EBM Conscientious, explicit, and judicious use Beyond clinical experience and physiologic

More information

Effect on sudden death

Effect on sudden death Effect on sudden death of heart failure treatment started with bisoprolol followed by enalapril, compared to the opposite order: Results of the randomized CIBIS III trial Ronnie Willenheimer Ass. Prof.

More information

Evidence Based Practice

Evidence Based Practice Evidence Based Practice RCS 6740 7/26/04 Evidence Based Practice: Definitions Evidence based practice is the integration of the best available external clinical evidence from systematic research with individual

More information

9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Pharmacotherapy Webinar Review Course Tuesday, September 3, 2013 Descriptive statistics:

More information

Epidemiologic Study Designs. (RCTs)

Epidemiologic Study Designs. (RCTs) Epidemiologic Study Designs Epidemiologic Study Designs Experimental (RCTs) Observational Analytical Descriptive Case-Control Cohort + cross-sectional & ecologic Epidemiologic Study Designs Descriptive

More information

Research Methodology Workshop. Study Type

Research Methodology Workshop. Study Type Research Methodology Workshop Study Type What type of question? Frequency: how common is it? Aetiology: What caused this? Intervention: Does this intervention work? Diagnosis or test evaluation: How accurate

More information

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial Experimental Design Chusak Okascharoen, MD, PhD September 19 th, 2016 Terminology Experimental study Clinical trial Randomized controlled trial 1 PHASES OF CLINICAL TRIALS Phase I: First-time-in-man studies

More information

Critical Appraisal Series

Critical Appraisal Series Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher

More information

The comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all.

The comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all. 1. RANDOMISED CONTROLLED TRIALS (Treatment studies) (Relevant JAMA User s Guides, Numbers IIA & B: references (3,4) Introduction: The most valid study design for assessing the effectiveness (both the benefits

More information

RANDOMIZED CLINICAL TRIALS. Study Designs. Randomized Clinical Trials (RCT) ASSIGN EXPOSURE Follow up Check for OUTCOME. Experimental studies

RANDOMIZED CLINICAL TRIALS. Study Designs. Randomized Clinical Trials (RCT) ASSIGN EXPOSURE Follow up Check for OUTCOME. Experimental studies RANDOMIZED CLINICAL TRIALS Study Designs Observational studies Analytic studies Descriptive studies Randomized Controlled trials Case control Cohort Cross sectional Randomized Clinical Trials (RCT) Assign

More information

Biostatistics 2 - Correlation and Risk

Biostatistics 2 - Correlation and Risk BROUGHT TO YOU BY Biostatistics 2 - Correlation and Risk Developed by Pfizer January 2018 This learning module is intended for UK healthcare professionals only. PP-GEP-GBR-0957 Date of preparation Jan

More information

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist.

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:

More information

Chapter 8 Statistical Principles of Design. Fall 2010

Chapter 8 Statistical Principles of Design. Fall 2010 Chapter 8 Statistical Principles of Design Fall 2010 Experimental Design Many interesting questions in biology involve relationships between response variables and one or more explanatory variables. Biology

More information

Glossary of Practical Epidemiology Concepts

Glossary of Practical Epidemiology Concepts Glossary of Practical Epidemiology Concepts - 2009 Adapted from the McMaster EBCP Workshop 2003, McMaster University, Hamilton, Ont. Note that open access to the much of the materials used in the Epi-546

More information

Journal Club Critical Appraisal Worksheets. Dr David Walbridge

Journal Club Critical Appraisal Worksheets. Dr David Walbridge Journal Club Critical Appraisal Worksheets Dr David Walbridge The Four Part Question The purpose of a structured EBM question is: To be directly relevant to the clinical situation or problem To express

More information

Overview. Goals of Interpretation. Methodology. Reasons to Read and Evaluate

Overview. Goals of Interpretation. Methodology. Reasons to Read and Evaluate Overview Critical Literature Evaluation and Biostatistics Ahl Ashley N. Lewis, PharmD, BCPS Clinical Specialist, Drug Information UNC Hospitals Background Review of basic statistics Statistical tests Clinical

More information

Critical Appraisal. Dave Abbott Senior Medicines Information Pharmacist

Critical Appraisal. Dave Abbott Senior Medicines Information Pharmacist Critical Appraisal Dave Abbott Senior Medicines Information Pharmacist Aims Identify key components of clinical trial design and apply these to a critical appraisal of the literature Be able to work out

More information

Evidence Informed Practice Online Learning Module Glossary

Evidence Informed Practice Online Learning Module Glossary Term Abstract Associations Attrition Bias Background and Significance Baseline Basic Science Bias Blinding Definition An abstract is a summary of a research article. It usually includes the purpose, methods,

More information

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH

More information

Making comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups

Making comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Making comparisons Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Data can be interpreted using the following fundamental

More information

Online Supplementary Material

Online Supplementary Material Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control

More information

研究設計理論 ( 一 ): RANDOMIZED TRIALS. 醫學研究初階課程 General Medicine, CGMH 劉素旬醫師 03/12/2013

研究設計理論 ( 一 ): RANDOMIZED TRIALS. 醫學研究初階課程 General Medicine, CGMH 劉素旬醫師 03/12/2013 1 研究設計理論 ( 一 ): RANDOMIZED TRIALS 醫學研究初階課程 General Medicine, CGMH 劉素旬醫師 03/12/2013 2 Learning Objectives Definition of a trial Features of trial design Elements of a trial Purposes of randomization and

More information

EBM, Study Design and Numbers. David Frankfurter, MD Professor OB/GYN The George Washington University

EBM, Study Design and Numbers. David Frankfurter, MD Professor OB/GYN The George Washington University EBM, Study Design and Numbers David Frankfurter, MD Professor OB/GYN The George Washington University 1978? 1978 Best Picture of 1978 The Deer Hunter Universal Studios The 50th Academy Awards were held

More information

EBM: Therapy. Thunyarat Anothaisintawee, M.D., Ph.D. Department of Family Medicine, Ramathibodi Hospital, Mahidol University

EBM: Therapy. Thunyarat Anothaisintawee, M.D., Ph.D. Department of Family Medicine, Ramathibodi Hospital, Mahidol University EBM: Therapy Thunyarat Anothaisintawee, M.D., Ph.D. Department of Family Medicine, Ramathibodi Hospital, Mahidol University How to appraise therapy literature Are the result valid? What are the result?

More information

INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD.

INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD. INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD. 1 OBJECTIVES By the end of this section, you will be able to: Provide a definition of epidemiology Describe the major types

More information

GATE CAT Intervention RCT/Cohort Studies

GATE CAT Intervention RCT/Cohort Studies GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence about interventions

More information

Critical Appraisal of Evidence

Critical Appraisal of Evidence Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies Bernadette Mazurek Melnyk, PhD, CPNP/PMHNP, FNAP, FAAN Associate Vice President for Health Promotion University Chief Wellness Officer

More information

Lecture 4. Analytical Interventional Studies

Lecture 4. Analytical Interventional Studies Lecture 4 Analytical Interventional Studies By the end of this lecture the student will be able to : Identify the concept of analytical Interventional studies Identify the concept of clinical trials and

More information

Critical Review Form Therapy Objectives: Methods:

Critical Review Form Therapy Objectives: Methods: Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To

More information

Rapid appraisal of the literature: Identifying study biases

Rapid appraisal of the literature: Identifying study biases Rapid appraisal of the literature: Identifying study biases Rita Popat, PhD Clinical Assistant Professor Division of Epidemiology Stanford University School of Medicine August 7, 2007 What is critical

More information

Proportions, risk ratios and odds ratios

Proportions, risk ratios and odds ratios Applied Biostatistics Proportions, risk ratios and odds ratios Martin Bland Professor of Health Statistics University of York http://www-users.york.ac.uk/~mb55/ Risk difference Difference between proportions:

More information

Outline. What is Evidence-Based Practice? EVIDENCE-BASED PRACTICE. What EBP is Not:

Outline. What is Evidence-Based Practice? EVIDENCE-BASED PRACTICE. What EBP is Not: Evidence Based Practice Primer Outline Evidence Based Practice (EBP) EBP overview and process Formulating clinical questions (PICO) Searching for EB answers Trial design Critical appraisal Assessing the

More information

Causal Association : Cause To Effect. Dr. Akhilesh Bhargava MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur

Causal Association : Cause To Effect. Dr. Akhilesh Bhargava MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur Causal Association : Cause To Effect Dr. MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur Measure of Association- Concepts If more disease occurs in a group that smokes compared to the

More information

Generalizing the right question, which is?

Generalizing the right question, which is? Generalizing RCT results to broader populations IOM Workshop Washington, DC, April 25, 2013 Generalizing the right question, which is? Miguel A. Hernán Harvard School of Public Health Observational studies

More information

Is There An Association?

Is There An Association? Is There An Association? Exposure (Risk Factor) Outcome Exposures Risk factors Preventive measures Management strategy Independent variables Outcomes Dependent variable Disease occurrence Lack of exercise

More information

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial)

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) William B. White, MD, for the CARES Investigators Calhoun Cardiology Center University

More information

Types of Biomedical Research

Types of Biomedical Research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency Family Medicine Section of

More information

12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C

12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C Types of Biomedical Research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency

More information

Systematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai

Systematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai Systematic reviews: From evidence to recommendation Session 2 - June 18, 2014 Going beyond design, going beyond intervention: The American Academy of Neurology (AAN) Clinical Practice Guideline process

More information

CHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials

CHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule

More information

Designed Experiments have developed their own terminology. The individuals in an experiment are often called subjects.

Designed Experiments have developed their own terminology. The individuals in an experiment are often called subjects. When we wish to show a causal relationship between our explanatory variable and the response variable, a well designed experiment provides the best option. Here, we will discuss a few basic concepts and

More information

Experimental and Quasi-Experimental designs

Experimental and Quasi-Experimental designs External Validity Internal Validity NSG 687 Experimental and Quasi-Experimental designs True experimental designs are characterized by three "criteria for causality." These are: 1) The cause (independent

More information

Study Designs in Epidemiology

Study Designs in Epidemiology Study Designs in Epidemiology Dr. Sireen Alkhaldi, BDS, MPH, DrPH First semester 2017/ 2018 Department of Family and Community Medicine School of Medicine/ The University of Jordan Epidemiologic Study

More information

exposure/intervention

exposure/intervention Kathleen A. Kennedy, MD, MPH University of Texas Medical School at Houston Medical School Most clinical research evaluates an association between exposure/intervention outcome. 1 Does the investigator

More information

Cost-effectiveness of influenza vaccines and economic evaluation of its impact

Cost-effectiveness of influenza vaccines and economic evaluation of its impact Cost-effectiveness of influenza vaccines and economic evaluation of its impact Anban Pillay Deputy Director General National Department of Health Republic of South Africa pillayanban@yahoo.com.au George

More information

CLINICAL DECISION USING AN ARTICLE ABOUT TREATMENT JOSEFINA S. ISIDRO LAPENA MD, MFM, FPAFP PROFESSOR, UPCM

CLINICAL DECISION USING AN ARTICLE ABOUT TREATMENT JOSEFINA S. ISIDRO LAPENA MD, MFM, FPAFP PROFESSOR, UPCM CLINICAL DECISION USING AN ARTICLE ABOUT TREATMENT JOSEFINA S. ISIDRO LAPENA MD, MFM, FPAFP PROFESSOR, UPCM Principles of Decision Making Knowing the patient s true state is often unnecessary Does my patient

More information

Study Designs. Randomized Clinical Trials (RCT) RCT: Example 1. RCT: Two by Two Table. Outcome. Exposure. Yes a b No c d

Study Designs. Randomized Clinical Trials (RCT) RCT: Example 1. RCT: Two by Two Table. Outcome. Exposure. Yes a b No c d Study Designs Randomized Clinical Trials (RCT) Assign Exposure Randomly Experimental studies Analytic studies Observational studies Descriptive studies POPULATION Population People without the outcome

More information

CTRI Dataset and Description

CTRI Dataset and Description CTRI Dataset and Description CTRI Field Description Public title of study Title intended for the lay public in easily understood language. Example: A clinical trial to study the effects of two drugs, ramipril

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial)

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) William B. White, MD for the CARES Investigators Calhoun Cardiology Center University

More information

Assessing Cardiovascular risk in different populations

Assessing Cardiovascular risk in different populations A-1 Assessing Cardiovascular risk in different populations Murray Stewart (GSK) A-2 Studies with RSG across different risk population Short term studies low risk ADOPT newly diagnosed low risk DREAM IGT

More information

UNIT I SAMPLING AND EXPERIMENTATION: PLANNING AND CONDUCTING A STUDY (Chapter 4)

UNIT I SAMPLING AND EXPERIMENTATION: PLANNING AND CONDUCTING A STUDY (Chapter 4) UNIT I SAMPLING AND EXPERIMENTATION: PLANNING AND CONDUCTING A STUDY (Chapter 4) A DATA COLLECTION (Overview) When researchers want to make conclusions/inferences about an entire population, they often

More information

Top 5 (Topics) Papers In GIM Rocky Mountain ACP Internal Medicine Meeting Raj Padwal November 13, 2008

Top 5 (Topics) Papers In GIM Rocky Mountain ACP Internal Medicine Meeting Raj Padwal November 13, 2008 Top 5 (Topics) Papers In GIM 2008 Rocky Mountain ACP Internal Medicine Meeting Raj Padwal November 13, 2008 Methods Searched ACPJC/EBM, TOC of top medical journals, MEDSCAPE Best Evidence, consultation

More information

HARM. Definition modified from the IHI definition of Harm by the QUEST Harm Workgroup

HARM. Definition modified from the IHI definition of Harm by the QUEST Harm Workgroup Indonesia Clinical epidemiology and Evidence Based Medicine (ICE(ICE-EBM) HARM Jarir At Thobari (FK UGM) Efficacious Medical intervention Harm HARM Unintended physical injury resulting from or contributed

More information

CONSORT 2010 checklist of information to include when reporting a randomised trial*

CONSORT 2010 checklist of information to include when reporting a randomised trial* CONSORT 2010 checklist of information to include when reporting a randomised trial* Section/Topic Title and abstract Introduction Background and objectives Item No Checklist item 1a Identification as a

More information

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Prevention of dementia Author Daniel Press, MD Michael Alexander, MD Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Deputy Editor Janet L Wilterdink, MD Last literature review version

More information

Clinical problems and choice of study designs

Clinical problems and choice of study designs Evidence Based Dentistry Clinical problems and choice of study designs Asbjørn Jokstad University of Oslo, Norway Nov 21 2001 1 Manipulation with intervention Yes Experimental study No Non-experimental

More information

Clinical Evidence: Asking the Question and Understanding the Answer. Keeping Up to Date. Keeping Up to Date

Clinical Evidence: Asking the Question and Understanding the Answer. Keeping Up to Date. Keeping Up to Date Clinical Evidence: Asking the Question and Understanding the Answer Keeping Up to Date 5,000? per day 1,500 per day 95 per day Keeping Up to Date 5,000? per day 1,500 per day 95 per day 1 Bias Bias refers

More information

Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout

Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Philippine Journal of Internal Medicine Meta-Analysis Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Erika Bianca S. Villazor-Isidro, M.D.*; John Carlo G.

More information

GATE: Graphic Appraisal Tool for Epidemiology picture, 2 formulas & 3 acronyms

GATE: Graphic Appraisal Tool for Epidemiology picture, 2 formulas & 3 acronyms GATE: Graphic Appraisal Tool for Epidemiology 1991-2015 1 picture, 2 formulas & 3 acronyms 1 GATE: Graphic Appraisal Tool for Epidemiology Graphic Architectural Tool for Epidemiology Graphic Approach To

More information

Issues to Consider in the Design of Randomized Controlled Trials

Issues to Consider in the Design of Randomized Controlled Trials Issues to Consider in the Design of Randomized Controlled Trials Jay Wilkinson, MD, MPH Professor of Pediatrics & Epidemiology Miller School of Medicine Seminar Purpose To facilitate an interactive discussion

More information

Musculoskeletal Annotated Bibliography

Musculoskeletal Annotated Bibliography Musculoskeletal Annotated Bibliography Clinical Question: Is Kinesio taping effective in improving ROM and/or pain in the treatment of shoulder injuries? Thelen MD, Dauber JA, Stoneman PD. The clinical

More information

Clinical Study Design: From Pilot to Randomized Controlled Trials

Clinical Study Design: From Pilot to Randomized Controlled Trials Clinical Study Design: From Pilot to Randomized Controlled Trials Thomas C. Hulsey, MSPH, Sc.D. Professor and Chair, Department of Epidemiology Director, Clinical Research Education, CTSI What is a clinical

More information

Department of OUTCOMES RESEARCH

Department of OUTCOMES RESEARCH Department of OUTCOMES RESEARCH Clinical Research Design Sources of Error Types of Clinical Research Randomized Trials! Daniel I. Sessler, M.D. Professor and Chair Department of OUTCOMES RESEARCH The Cleveland

More information

the standard deviation (SD) is a measure of how much dispersion exists from the mean SD = square root (variance)

the standard deviation (SD) is a measure of how much dispersion exists from the mean SD = square root (variance) Normal distribution The normal distribution is also known as the Gaussian distribution or 'bell-shaped' distribution. It describes the spread of many biological and clinical measurements Properties of

More information

Appendix 2 Quality assessment tools. Cochrane risk of bias tool for RCTs. Support for judgment

Appendix 2 Quality assessment tools. Cochrane risk of bias tool for RCTs. Support for judgment Appendix 2 Quality assessment tools Cochrane risk of bias tool for RCTs Item Judgment (H/L/Unclear) Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants

More information

Evaluating Effectiveness of Treatments. Elenore Judy B. Uy, M.D.

Evaluating Effectiveness of Treatments. Elenore Judy B. Uy, M.D. Evaluating Effectiveness of Treatments Elenore Judy B. Uy, M.D. OUTLINE 1. Why evaluate effectiveness 2. How to acquire evidence 3. How to appraise evidence Directness Validity Results 4. Our Case WALA

More information

rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd.

rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd. rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product

More information

Epidemiology & Evidence Based Medicine. Patrick Linden & Matthew McCall

Epidemiology & Evidence Based Medicine. Patrick Linden & Matthew McCall Epidemiology & Evidence Based Medicine Patrick Linden & Matthew McCall Areas Covered in this Talk Bradford Hill Criteria Bias and confounding Study designs, advantages and disadvantages Basic definitions

More information

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 DETAILED COURSE OUTLINE Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 Hal Morgenstern, Ph.D. Department of Epidemiology UCLA School of Public Health Page 1 I. THE NATURE OF EPIDEMIOLOGIC

More information

An Introduction to Epidemiology

An Introduction to Epidemiology An Introduction to Epidemiology Wei Liu, MPH Biostatistics Core Pennington Biomedical Research Center Baton Rouge, LA Last edited: January, 14 th, 2014 TABLE OF CONTENTS Introduction.................................................................

More information

CRITICAL APPRAISAL WORKSHEET

CRITICAL APPRAISAL WORKSHEET 1. THE RESEARCH QUESTION CRITICAL APPRAISAL WORKSHEET 1a. What question did the researchers want to answer? About the magnitude of health problem? About the impact of a therapy of some sort? Any differences

More information

Structural Approach to Bias in Meta-analyses

Structural Approach to Bias in Meta-analyses Original Article Received 26 July 2011, Revised 22 November 2011, Accepted 12 December 2011 Published online 2 February 2012 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/jrsm.52 Structural

More information

Do the sample size assumptions for a trial. addressing the following question: Among couples with unexplained infertility does

Do the sample size assumptions for a trial. addressing the following question: Among couples with unexplained infertility does Exercise 4 Do the sample size assumptions for a trial addressing the following question: Among couples with unexplained infertility does a program of up to three IVF cycles compared with up to three FSH

More information

What is the Cochrane Collaboration? What is a systematic review?

What is the Cochrane Collaboration? What is a systematic review? 1 What is the Cochrane Collaboration? What is a systematic review? Archie Cochrane (1909-1988) It is surely a great criticism of our profession that we have not organised a critical summary, by specialty

More information

Common Statistical Issues in Biomedical Research

Common Statistical Issues in Biomedical Research Common Statistical Issues in Biomedical Research Howard Cabral, Ph.D., M.P.H. Boston University CTSI Boston University School of Public Health Department of Biostatistics May 15, 2013 1 Overview of Basic

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

Principles of Experimental Design

Principles of Experimental Design Principles of Experimental Design Bret Hanlon and Bret Larget Department of Statistics University of Wisconsin Madison November 15, 2011 Designing Experiments 1 / 31 Experimental Design Many interesting

More information

Principles of Experimental Design

Principles of Experimental Design Principles of Experimental Design Bret Hanlon and Bret Larget Department of Statistics University of Wisconsin Madison November 15, 2011 Designing Experiments 1 / 31 Experimental Design Many interesting

More information

Extended Hormonal Therapy

Extended Hormonal Therapy Extended Hormonal Therapy Dr. Caroline Lohrisch, Medical Oncologist, BC Cancer Agency Vancouver Centre November 1, 2014 www.fpon.ca Optimal Endocrine Therapy for Women with Hormone Receptor Positive Early

More information

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard

More information

Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies

Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies Bernadette Mazurek Melnyk, PhD, CPNP/PMHNP, FAANP, FAAN Associate Vice President for Health Promotion University Chief Wellness

More information

Critical Appraisal of Research Protocol

Critical Appraisal of Research Protocol Critical Appraisal of Research Protocol Moazzam Ali MD, PhD, MPH Department of Reproductive Health and Research World Health Organization Geneva, Switzerland GFMER November 27, 2017 1 Today's presentation

More information

Challenges of Observational and Retrospective Studies

Challenges of Observational and Retrospective Studies Challenges of Observational and Retrospective Studies Kyoungmi Kim, Ph.D. March 8, 2017 This seminar is jointly supported by the following NIH-funded centers: Background There are several methods in which

More information

Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto

Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death Debra Moy Faculty of Pharmacy University of Toronto Goal To provide practitioners with a systematic approach to evaluating a meta analysis

More information

PhD Course in Biostatistics

PhD Course in Biostatistics PhD Course in Biostatistics Univ.-Prof. DI Dr. Andrea Berghold Institute for Medical Informatics, Statistics and Documentation Medical University of Graz andrea.berghold@medunigraz.at Content Introduction

More information

INTERNAL VALIDITY, BIAS AND CONFOUNDING

INTERNAL VALIDITY, BIAS AND CONFOUNDING OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand

More information